Clinical Trial Update: A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 pediatric study evaluating a plerixafor-containing regimen as part of a second allogeneic stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED